Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 91

1.

Smoking is associated with higher disease-related costs and lower health-related quality-of-life in inflammatory bowel disease.

Severs M, Mangen MJ, van der Valk ME, Fidder HH, Dijkstra G, van der Have M, van Bodegraven AA, de Jong DJ, van der Woude CJ, Romberg-Camps M, Clemens C, Jansen JM, van de Meeberg PC, Mahmmod N, Ponsioen CY, Vermeijden JR, van der Meulen-de Jong AE, Pierik M, Siersema PD, Oldenburg B; COIN study group and the Dutch Initiative on Crohn and Colitis.

J Crohns Colitis. 2016 Sep 19. pii: jjw160. [Epub ahead of print]

PMID:
27647859
2.

Pooled Resequencing of 122 Ulcerative Colitis Genes in a Large Dutch Cohort Suggests Population-Specific Associations of Rare Variants in MUC2.

Visschedijk MC, Alberts R, Mucha S, Deelen P, de Jong DJ, Pierik M, Spekhorst LM, Imhann F, van der Meulen-de Jong AE, van der Woude CJ, van Bodegraven AA, Oldenburg B, Löwenberg M, Dijkstra G, Ellinghaus D, Schreiber S, Wijmenga C; Initiative on Crohn and Colitis; Parelsnoer Institute, Rivas MA, Franke A, van Diemen CC, Weersma RK.

PLoS One. 2016 Aug 4;11(8):e0159609. doi: 10.1371/journal.pone.0159609. eCollection 2016.

3.

Low levels of IgM antibodies recognizing oxidation-specific epitopes are associated with human non-alcoholic fatty liver disease.

Hendrikx T, Watzenböck ML, Walenbergh SM, Amir S, Gruber S, Kozma MO, Grabsch HI, Koek GH, Pierik MJ, Staufer K, Trauner M, Kalhan SC, Jonkers D, Hofker MH, Binder CJ, Shiri-Sverdlov R.

BMC Med. 2016 Jul 22;14(1):107. doi: 10.1186/s12916-016-0652-0.

4.

Inflammatory bowel disease, cancer and medication: Cancer risk in the Dutch population-based IBDSL cohort.

van den Heuvel TR, Wintjens DS, Jeuring SF, Wassink MH, Romberg-Camps MJ, Oostenbrug LE, Sanduleanu S, Hameeteman WH, Zeegers MP, Masclee AA, Jonkers DM, Pierik MJ.

Int J Cancer. 2016 Sep 15;139(6):1270-80. doi: 10.1002/ijc.30183. Epub 2016 May 31.

PMID:
27170593
5.

Editorial: additional evidence for drug-induced microscopic colitis - authors' reply.

Verhaegh BP, Pierik MJ, Jonkers DM.

Aliment Pharmacol Ther. 2016 Jun;43(12):1344-5. doi: 10.1111/apt.13640. No abstract available.

PMID:
27166986
6.

On the External Validity of Epidemiologic Data from Hospital-based IBD Cohorts.

van den Heuvel TR, Pierik MJ, Jonkers DM.

J Crohns Colitis. 2016 Apr 16. pii: jjw084. [Epub ahead of print] No abstract available.

PMID:
27085079
7.

[Chronic diarrhoea due to microscopic colitis: awareness pays].

Verhaegh BP, van Dijk MA, Goudkade D, Pierik MJ, Masclee AA.

Ned Tijdschr Geneeskd. 2016;160:A9584. Dutch.

PMID:
27071360
8.

High risk of drug-induced microscopic colitis with concomitant use of NSAIDs and proton pump inhibitors.

Verhaegh BP, de Vries F, Masclee AA, Keshavarzian A, de Boer A, Souverein PC, Pierik MJ, Jonkers DM.

Aliment Pharmacol Ther. 2016 May;43(9):1004-13. doi: 10.1111/apt.13583. Epub 2016 Mar 9.

PMID:
26956016
9.

Epidemiology and Long-term Outcome of Inflammatory Bowel Disease Diagnosed at Elderly Age-An Increasing Distinct Entity?

Jeuring SF, van den Heuvel TR, Zeegers MP, Hameeteman WH, Romberg-Camps MJ, Oostenbrug LE, Masclee AA, Jonkers DM, Pierik MJ.

Inflamm Bowel Dis. 2016 Jun;22(6):1425-34. doi: 10.1097/MIB.0000000000000738.

PMID:
26933752
10.

Plasma intestinal fatty acid-binding protein fails to predict endoscopic disease activity in inflammatory bowel disease patients.

Bodelier AG, Pierik MJ, Lenaerts K, de Boer E, Olde Damink SW, Hameeteman WM, Masclee AA, Jonkers DM.

Eur J Gastroenterol Hepatol. 2016 Jul;28(7):807-13. doi: 10.1097/MEG.0000000000000616.

PMID:
26919325
11.

Concordance in Anti-OmpC and Anti-I2 Indicate the Influence of Genetic Predisposition: Results of a European Study of Twins with Crohn's Disease.

Amcoff K, Joossens M, Pierik MJ, Jonkers D, Bohr J, Joossens S, Romberg-Camps M, Nyhlin N, Wickbom A, Rutgeerts PJ, Tysk C, Bodin L, Colombel JF, Vermeire S, Halfvarson J.

J Crohns Colitis. 2016 Jun;10(6):695-702. doi: 10.1093/ecco-jcc/jjw021. Epub 2016 Jan 27.

PMID:
26818662
12.

Non-adherence to Anti-TNF Therapy is Associated with Illness Perceptions and Clinical Outcomes in Outpatients with Inflammatory Bowel Disease: Results from a Prospective Multicentre Study.

van der Have M, Oldenburg B, Kaptein AA, Jansen JM, Scheffer RC, van Tuyl BA, van der Meulen-de Jong AE, Pierik M, Siersema PD, van Oijen MG, Fidder HH.

J Crohns Colitis. 2016 May;10(5):549-55. doi: 10.1093/ecco-jcc/jjw002. Epub 2016 Jan 6.

PMID:
26738757
13.

Smoking is Associated With Extra-intestinal Manifestations in Inflammatory Bowel Disease.

Severs M, van Erp SJ, van der Valk ME, Mangen MJ, Fidder HH, van der Have M, van Bodegraven AA, de Jong DJ, van der Woude CJ, Romberg-Camps MJ, Clemens CH, Jansen JM, van de Meeberg PC, Mahmmod N, Ponsioen CY, Bolwerk C, Vermeijden JR, Pierik MJ, Siersema PD, Leenders M, van der Meulen-de Jong AE, Dijkstra G, Oldenburg B; Dutch Initiative on Crohn and Colitis.

J Crohns Colitis. 2016 Apr;10(4):455-61. doi: 10.1093/ecco-jcc/jjv238. Epub 2015 Dec 30.

PMID:
26721937
14.

Better survival of renal cell carcinoma in patients with inflammatory bowel disease.

Derikx LA, Nissen LH, Drenth JP, van Herpen CM, Kievit W, Verhoeven RH, Mulders PF, Hulsbergen-van de Kaa CA, Boers-Sonderen MJ, van den Heuvel TR, Pierik M, Nagtegaal ID, Hoentjen F; Dutch Initiative on Crohn and Colitis; PALGA Group; IBD/RCC Group.

Oncotarget. 2015 Nov 10;6(35):38336-47. doi: 10.18632/oncotarget.5186.

15.

European Evidence-based Consensus: Inflammatory Bowel Disease and Malignancies.

Annese V, Beaugerie L, Egan L, Biancone L, Bolling C, Brandts C, Dierickx D, Dummer R, Fiorino G, Gornet JM, Higgins P, Katsanos KH, Nissen L, Pellino G, Rogler G, Scaldaferri F, Szymanska E, Eliakim R; ECCO.

J Crohns Colitis. 2015 Nov;9(11):945-65. doi: 10.1093/ecco-jcc/jjv141. Epub 2015 Aug 20. No abstract available.

PMID:
26294789
16.

Multimodal treatment of perianal fistulas in Crohn's disease: seton versus anti-TNF versus advancement plasty (PISA): study protocol for a randomized controlled trial.

de Groof EJ, Buskens CJ, Ponsioen CY, Dijkgraaf MG, D'Haens GR, Srivastava N, van Acker GJ, Jansen JM, Gerhards MF, Dijkstra G, Lange JF, Witteman BJ, Kruyt PM, Pronk A, van Tuyl SA, Bodelier A, Crolla RM, West RL, Vrijland WW, Consten EC, Brink MA, Tuynman JB, de Boer NK, Breukink SO, Pierik MJ, Oldenburg B, van der Meulen AE, Bonsing BA, Spinelli A, Danese S, Sacchi M, Warusavitarne J, Hart A, Yassin NA, Kennelly RP, Cullen GJ, Winter DC, Hawthorne AB, Torkington J, Bemelman WA.

Trials. 2015 Aug 20;16:366. doi: 10.1186/s13063-015-0831-x.

17.

Comparison of Costs and Quality of Life in Ulcerative Colitis Patients with an Ileal Pouch-Anal Anastomosis, Ileostomy and Anti-TNFα Therapy.

van der Valk ME, Mangen MJ, Severs M, van der Have M, Dijkstra G, van Bodegraven AA, Fidder HH, de Jong DJ, Pierik M, van der Woude CJ, Romberg-Camps MJ, Clemens CH, Jansen JM, van de Meeberg PC, Mahmmod N, van der Meulen-de Jong AE, Ponsioen CY, Bolwerk C, Vermeijden JR, Siersema PD, Leenders M, Oldenburg B; COIN study group; Dutch Initiative on Crohn and Colitis.

J Crohns Colitis. 2015 Nov;9(11):1016-23. doi: 10.1093/ecco-jcc/jjv134. Epub 2015 Aug 7.

PMID:
26254056
18.

Volatile Organic Compounds in Exhaled Air as Novel Marker for Disease Activity in Crohn's Disease: A Metabolomic Approach.

Bodelier AG, Smolinska A, Baranska A, Dallinga JW, Mujagic Z, Vanhees K, van den Heuvel T, Masclee AA, Jonkers D, Pierik MJ, van Schooten FJ.

Inflamm Bowel Dis. 2015 Aug;21(8):1776-85. doi: 10.1097/MIB.0000000000000436.

PMID:
26199990
19.

Disease Outcome of Ulcerative Colitis in an Era of Changing Treatment Strategies: Results from the Dutch Population-Based IBDSL Cohort.

Jeuring SF, Bours PH, Zeegers MP, Ambergen TW, van den Heuvel TR, Romberg-Camps MJ, van Bodegraven AA, Oostenbrug LE, Breukink SO, Stassen LP, Hameeteman WH, Masclee AA, Jonkers DM, Pierik MJ.

J Crohns Colitis. 2015 Oct;9(10):837-45. doi: 10.1093/ecco-jcc/jjv129. Epub 2015 Jul 17.

PMID:
26188352
20.

Identification of Patients With Variants in TPMT and Dose Reduction Reduces Hematologic Events During Thiopurine Treatment of Inflammatory Bowel Disease.

Coenen MJ, de Jong DJ, van Marrewijk CJ, Derijks LJ, Vermeulen SH, Wong DR, Klungel OH, Verbeek AL, Hooymans PM, Peters WH, te Morsche RH, Newman WG, Scheffer H, Guchelaar HJ, Franke B; TOPIC Recruitment Team.

Gastroenterology. 2015 Oct;149(4):907-17.e7. doi: 10.1053/j.gastro.2015.06.002. Epub 2015 Jun 11.

PMID:
26072396
Items per page

Supplemental Content

Loading ...
Write to the Help Desk